Shareholders sue InVivo Therapeutics and former CEO Frank Reynolds, alleging that the company concealed how long it would take to run a clinical trial under FDA guidelines.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1qqFi6m
Cap comentari:
Publica un comentari a l'entrada